The South and Central America Neurovascular Catheters market is projected to increase from US$ 149.5 million in 2024 to US$ 295.0 million by 2033, registering a CAGR of 8.1% during 2025–2033.
Brazil leads the regional market, supported by continuous investments in hospital infrastructure, advanced imaging systems, and specialized training programs for neurologists that enable catheter-based interventions for ischemic stroke and cerebral aneurysms. Mexico, Argentina, and Colombia are also emerging as high-growth markets, with tertiary care hospitals increasingly adopting mechanical thrombectomy, embolization, and flow diversion procedures as part of standard neurovascular treatment pathways.
Stroke remains a leading cause of disability across South and Central America, driving demand for mechanical thrombectomy procedures. Neurovascular catheters — including thrombectomy, access, and microcatheters — are essential for navigating complex cerebral vasculature and restoring blood flow in large vessel occlusion cases. The rising prevalence of risk factors such as hypertension, diabetes, and obesity, along with stronger public health awareness campaigns focused on early stroke intervention, is further expanding procedural volumes in urban healthcare centers.
Healthcare system reforms in countries such as Brazil and Colombia are improving access to advanced diagnostic imaging (CT and MRI) and interventional suites, enabling earlier detection and treatment of aneurysms and arteriovenous malformations. Private hospitals and specialized stroke centers remain the primary adopters of next-generation catheter technologies, while public healthcare institutions are gradually integrating these solutions as infrastructure and funding improve. Strategic collaborations between global MedTech companies and local distributors are enhancing product availability, clinician training, and post-market support across the region.
Key market segments include product type, coating type, lumen configuration, and end user.
By product, the market includes thrombectomy catheters, embolization catheters, microcatheters, IVUS catheters, balloon catheters, and others, with thrombectomy catheters leading in 2024 due to high procedural volumes in acute stroke management.
By coating type, coated catheters dominate the market, supported by infection-control priorities in tertiary care environments.
Based on lumen, multi-lumen catheters hold the largest share, driven by their ability to support simultaneous therapeutic delivery.
By end user, hospitals and clinics remain the dominant segment, reflecting high procedural concentration and established stroke care infrastructure.
The South and Central America Neurovascular Catheters Market (2025–2033) report provides comprehensive analysis of market size, forecasts, trends, competitive landscape, regulatory environment, and regional developments. It covers key countries including Brazil, Argentina, Peru, Chile, and Colombia, with Brazil accounting for the largest share in 2024.
Market dynamics vary across the region. Brazil leads adoption with high procedural volumes in major cities such as São Paulo, Rio de Janeiro, and Brasília, supported by expanding stroke centers and catheterization labs. Mexico is strengthening neurovascular capabilities across major urban hospitals, while Argentina is advancing in Buenos Aires and Córdoba through increased healthcare spending. Colombia is witnessing early adoption of advanced technologies, including robotic-assisted thrombectomy in select centers. Chile and Peru are gradually expanding access to catheter-based stroke care, primarily in urban hospitals.
Across the region, hospitals and clinics remain the primary end users, while diagnostic imaging centers with interventional capabilities are slowly expanding their role. Although disparities persist between urban and rural healthcare access, ongoing investments, training initiatives, and infrastructure development are steadily improving adoption of neurovascular catheter technologies across South and Central America.